BioSpace News Archive

Array BioPharma, Inc.Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the 2018 Cantor Global Healthcare Conference in New York.

AcelRx Pharmaceuticals Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be presenting at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference.

Akebia Therapeutics, Inc. today announced that it will participate in the following investor conferences:

Presentation to be webcast on www.exelixis.com

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has completed enrollment for the AURORA Phase 3 trial ahead of schedule.

SurGenTec ® LLC has been awarded the 2018 Orthopedics This Week Spine Technology Award and will be formally receiving their award during the 2018 North American Spine Society meeting.

Synlogic announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s interim president and chief executive officer, and chief medical officer, will present a corporate update at the Leerink Partners Roundtable Series on Rare Diseases and Oncology at 11:30 am ET on Tuesday, October 2, 2018, in New York City.

Verastem Oncology to Receive an Upfront Payment of $15 Million USD; Then Eligible to Receive Up To $30 Million USD in Development Milestone Payments as well as Sales Milestone and Double-Digit Percentage Royalty Payments

Alexion Pharmaceuticals today announced that management will present at the Leerink Partners Roundtable Series: Rare Disease & Oncology in New York, NY on Tuesday, October 2, 2018 at 10 a.m., EDT.

Today, the Pharmaceutical Care Management Association (PCMA) welcomes Labeed Diab, RPh, President, Humana Pharmacy Solutions, as the newest member of the PCMA Board of Directors.